Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (688621.SS) SHH

Currency In CNY

AD

Valuation

Market Cap6.81B
Enterprise Value6.92B
P/E Ratio28.55
PEG Ratio0.67
Price/Sales Ratio4.59
Price/Book Ratio4.44
Enterprise/Revenue4.76
Enterprise/EBITDA26.42

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.16
Operating Margin0.17
AD

Management Effectiveness

Return On Assets0.08
Return On Equity0.16

Income Statement

Revenue1.22B
Revenue/Share10.33
Gross Profit634.32M
EBITDA277.26M
Net Income203.87M
Diluted EPS1.86

Balance Sheet

Total Cash419.45M
Total Cash/Share3.66
Total Debt574.03M
Total Debt/Equity0.46
Current Ratio1.79
Book Value Per Share11.06

Price History

52-Week Change-6.09
52-Week High86.5
52-Week Low46.68
Moving Average 50 Days54.27
Moving Average 200 Days62.05

Statistics

Average Volume2.17M
Shares Outstanding112M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.19
Trailing Annual Dividend Yield0.39
Payout Ratio0.15
Last Split Factor7:5
Last Split DateMay 12, 2023
AD